206 related articles for article (PubMed ID: 7520211)
1. The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum alpha-fetoprotein levels.
Christmas JT; Vanner LV; Daniels RM; Bodurtha JN; Hays PM; Redwine FO
Am J Obstet Gynecol; 1994 Aug; 171(2):315-9; discussion 319-20. PubMed ID: 7520211
[TBL] [Abstract][Full Text] [Related]
2. Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Bernstein IM; Barth RA; Miller R; Capeless EL
Obstet Gynecol; 1992 Jan; 79(1):71-4. PubMed ID: 1370124
[TBL] [Abstract][Full Text] [Related]
3. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
[TBL] [Abstract][Full Text] [Related]
4. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Simpson JL; Palomaki GE; Mercer B; Haddow JE; Andersen R; Sibai B; Elias S
Am J Obstet Gynecol; 1995 Dec; 173(6):1742-8. PubMed ID: 8610755
[TBL] [Abstract][Full Text] [Related]
5. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Huerta-Enochian G; Katz V; Erfurth S
Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
[TBL] [Abstract][Full Text] [Related]
6. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
7. Raised maternal serum-alpha-fetoprotein levels and spontaneous fetomaternal transfusion.
Los FJ; de Wolf BT; Huisjes HJ
Lancet; 1979 Dec; 2(8154):1210-2. PubMed ID: 92622
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic use of meternal serum alpha-fetoprotein levels.
Cowchock FS; Jackson LG
Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
[TBL] [Abstract][Full Text] [Related]
10. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
Salafia CM; DeVore GR; Mainolfi E; Kelly J; Pezzullo JC; Rothlein R
Am J Obstet Gynecol; 1993 Oct; 169(4):830-4. PubMed ID: 7694462
[TBL] [Abstract][Full Text] [Related]
11. Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.
Spaggiari E; Ruas M; Dreux S; Valat AS; Czerkiewicz I; Guimiot F; Schmitz T; Delezoide AL; Muller F
Am J Obstet Gynecol; 2013 Apr; 208(4):303.e1-7. PubMed ID: 23313312
[TBL] [Abstract][Full Text] [Related]
12. Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Simpson JL; Elias S; Morgan CD; Andersen RN; Shulman LP; Sibai BM; Mercer BM; Skoll A
Am J Obstet Gynecol; 1991 Mar; 164(3):829-36. PubMed ID: 1706141
[TBL] [Abstract][Full Text] [Related]
13. Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome?
Başbuğ D; Başbuğ A; Gülerman C
Ginekol Pol; 2017; 88(6):325-330. PubMed ID: 28727133
[TBL] [Abstract][Full Text] [Related]
14. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
[TBL] [Abstract][Full Text] [Related]
15. Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha-fetoprotein levels. A case report.
Downing GJ; Kilbride HW; Yeast JD
J Reprod Med; 1990 Apr; 35(4):444-6. PubMed ID: 1693688
[TBL] [Abstract][Full Text] [Related]
16. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Spong CY; Ghidini A; Walker CN; Ossandon M; Pezzullo JC
Am J Obstet Gynecol; 1997 Nov; 177(5):1085-7. PubMed ID: 9396898
[TBL] [Abstract][Full Text] [Related]
17. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
Konchak PS; Bernstein IM; Capeless EL
Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
Davis RO; Goldenberg RL; Boots L; Hoffman HJ; Copper R; Cutter GR; DuBard MB; Cliver SP; Smith RK
Am J Obstet Gynecol; 1992 Sep; 167(3):596-601. PubMed ID: 1382388
[TBL] [Abstract][Full Text] [Related]
19. Unexplained elevated maternal serum alpha-fetoprotein levels and perinatal outcome in an urban clinic population.
Brazerol WF; Grover S; Donnenfeld AE
Am J Obstet Gynecol; 1994 Oct; 171(4):1030-5. PubMed ID: 7524321
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Waller DK; Lustig LS; Cunningham GC; Golbus MS; Hook EB
N Engl J Med; 1991 Jul; 325(1):6-10. PubMed ID: 1710779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
